Wed, March 1, 2023
Tue, February 28, 2023
Mon, February 27, 2023

Matthew Sykes Maintained (CDNA) at Strong Buy with Decreased Target to $25 on, Feb 28th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-25-on-feb-28th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Sykes of Goldman Sachs, Maintained "CareDx, Inc" (CDNA) at Strong Buy with Decreased Target from $29 to $25 on, Feb 28th, 2023.

Matthew has made no other calls on CDNA in the last 4 months.



There is 1 other peer that has a rating on CDNA. Out of the 1 peers that are also analyzing CDNA, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Andrew Cooper of "Raymond James" Maintained at Strong Buy with Decreased Target to $24 on, Tuesday, January 31st, 2023

Publication Contributing Sources